Earnings Call · Q4 FY2024·2025-02-26

Q4 24EPS +8.39%·Rev n/aQ3 24EPS +2.86%·Rev n/aQ2 24EPS +17.24%·Rev n/aQ1 24EPS -9.52%·Rev n/a⚠ consensus missing

AVANOS MEDICAL, INC. AVNS

Scott Galovan — Host/Investor Relations

Michael Greiner — Interim CEO

+0.4%1d on move date+0.3% vs SPY3d−3.3%5d−3.5%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AVNS calls or request research access.

More AVNS calls Browse calls Request research access